The Clinical Significance of CT-based Biomarkers in the Classification and Prognosis of Bronchiectasis

Recruiting now

Conditions studied: Bronchiectasis

In brief

As the third major chronic airway disease in China, bronchiectasis has a wide range of patients. However, the involved sites, morphological features and airway obstruction of bronchiectasis are varied, and clinical heterogeneity is high, making prognosis and severity difficult to evaluate. CT plays an important role in the diagnosis and classification of ramadasis. Based on this, we analyzed the CT findings of patients with bronchiectasis and followed up patients with bronchiectasis to understand their disease progression and prognosis, so as to further analyze the role of CT biomarkers in the type and prognosis of bronchiectasis diseases.

Key facts

Study ID

NCT06346938

Run by

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

People needed

300

Starts

2024-03-30

Expected to finish

2027-03-26

Last updated by the study team

2025-08-19

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years and above;
• Can cooperate with CT scan;
• Bronchiectasis confirmed by high-resolution computed tomography of the lungs;
• Can provide written informed consent

You may not qualify if…

• Pulmonary surgery;
• Patients with lung cancer, asthma and other respiratory diseases;
• Tractive bronchiectasis caused by pulmonary fibrosis;
• Patients with malignant tumors or serious dysfunction of the heart, brain, kidney and other important systems can not cooperate with the completion of this study；
• Lack of important clinical information.

Where it is running

• Wuhan Union Hospital — Wuhan, Hubei, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.